ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Adamas Completes Acquisition of OSMOLEX ER
January 14, 2021Adamas Pharmaceuticals announced the closing of the settlement of patent litigation with Osmotica Pharmaceutical, a subsidiary of Osmotica Pharmaceuticals and completes the acquisition of the global rights to OSMOLEX ER®. -
Adamas Announces Patent for GOCOVRI in Parkinson’s Disease
May 19, 2020Adamas Pharmaceuticals has been issued a new patent (no. 10,646,456) by the United States Patent and Trademark Office (USPTO) that covers GOCOVRI® (amantadine) extended release capsules. -
Adamas Announces Settlement of Patent Litigation with Sandoz
January 03, 2020Adamas has entered into a Settlement Agreement with Sandoz resolving its ongoing litigation concerning Sandoz’s Abbreviated New Drug Application (ANDA) seeking approval by ... -
DocDoc raises $5.45 M for product scaling
March 21, 2018DocDoc controls the latest in clinical informatics, artificial intelligence and healthcare quality assessment across Asia's largest healthcare provider network to deliver powerful solutions -
Adamas scores orphan approval for tweaked generic Parkinson's med
August 28, 2017Adamas' Gocovri is an extended-release formulation of generic amantadine.
Pharma Sources Insight January 2025
